Zhang, M., Yang, L., Hou, L., & Tang, X. (2021). LncRNA SNHG1 promotes tumor progression and cisplatin resistance through epigenetically silencing miR-381 in breast cancer. Taylor & Francis Group.
Chicago Style (17th ed.) CitationZhang, Mingkun, Liu Yang, Lan Hou, and Xueyuan Tang. LncRNA SNHG1 Promotes Tumor Progression and Cisplatin Resistance Through Epigenetically Silencing MiR-381 in Breast Cancer. Taylor & Francis Group, 2021.
MLA (8th ed.) CitationZhang, Mingkun, et al. LncRNA SNHG1 Promotes Tumor Progression and Cisplatin Resistance Through Epigenetically Silencing MiR-381 in Breast Cancer. Taylor & Francis Group, 2021.
Warning: These citations may not always be 100% accurate.